Concepedia

Solid Tumor Fusions

Solid Tumor Fusions is a genomic aberration characterized by the abnormal joining of two distinct genes specifically arising in non-hematological, tissue-based malignancies, distinguished from other gene fusions by their occurrence exclusively within solid tumor contexts.

15

Publications

3.4K

Citations

208

Authors

169

Institutions

Publications per year

2017–2026

13

Parents

Publications

15

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

Robert C. Doebele, Alexander Drilon, Luis Paz‐Ares et al. · The Lancet Oncology · 2019 · 1.7K citations · Full text

, , +9

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

David S. Hong, Steven G. DuBois, Shivaani Kummar et al. · The Lancet Oncology · 2020 · 994 citations · Full text

, , +14

Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study

David S. Hong, Todd M. Bauer, Afshin Dowlati et al. · Annals of Oncology · 2019 · 153 citations · Full text

, , +15

A Multiplex Real-Time PCR Assay for the Detection of Gene Fusions Observed in Solid Tumors

Martine Peter, Elisabeth Gilbert, Olivier Delattre · Laboratory Investigation · 2001 · 121 citations · Full text

, , +17

Clinicopathologic Features and Response to Therapy of<i>NRG1</i>Fusion–Driven Lung Cancers: The eNRGy1 Global Multicenter Registry

Alexander Drilon, M. Duruisseaux, Ji‐Youn Han et al. · Journal of Clinical Oncology · 2021 · 79 citations · Full text

, , +4

1–5 of 15

Authors

208

  1. SV
    Stephen V. Liu

    Georgetown University, United States

    5 publications · 1.9K citations

    5

    h-index

  2. RC
    Robert C. Doebele

    University of Colorado Denver, United States

    4 publications · 2K citations

    4

    h-index

  3. AD
    Alexander Drilon

    Memorial Sloan Kettering Cancer Center, United States

    4 publications · 2.9K citations

    4

    h-index

  4. VW
    Viola W. Zhu

    University of California, Irvine, United States

    3 publications · 136 citations

    3

    h-index

  5. AF
    Anna F. Farago

    Massachusetts General Hospital, United States

    3 publications · 2.9K citations

    3

    h-index

1–5 of 208

Institutions

169

  1. Georgetown University

    Washington, United States

    6 h-index

    7 publications

    2K citations

  2. Massachusetts General Hospital

    Boston, United States

    5 h-index

    7 publications

    4.9K citations

  3. Memorial Sloan Kettering Cancer Center

    New York, United States

    5 h-index

    12 publications

    5.3K citations

  4. University of Southern California

    Los Angeles, United States

    4 h-index

    4 publications

    2.8K citations

  5. Harvard University

    Cambridge, United States

    4 h-index

    4 publications

    2.8K citations

  6. University of Colorado Denver

    Denver, United States

    4 h-index

    5 publications

    2.1K citations

  7. The University of Texas MD Anderson Cancer Center

    Houston, United States

    3 h-index

    6 publications

    1.5K citations

  8. Heidelberg University

    Heidelberg, Germany

    3 h-index

    5 publications

    3.1K citations

1–8 of 169

Venues

  1. Journal of Clinical Oncology

    3 publications · 155 citations

    3

    h-index

  2. The Lancet Oncology

    2 publications · 2.7K citations

    2

    h-index

  3. Lung Cancer

    1 publications · 20 citations

    1

    h-index

  4. Annals of Diagnostic Pathology

    1 publications · 27 citations

    1

    h-index

  5. Cancer

    1 publications · 42 citations

    1

    h-index

1–5